Istalol

— THERAPEUTIC CATEGORIES —
  • Glaucoma

Istalol Generic Name & Formulations

General Description

Timolol (as maleate) 0.5%; oph soln; contains benzalkonium chloride.

Pharmacological Class

Noncardioselective beta-blocker.

How Supplied

Soln—5mL

Manufacturer

Istalol Indications

Indications

Open-angle glaucoma. Ocular hypertension.

Istalol Dosage and Administration

Adult

1 drop in affected eye(s) once daily in the AM.

Children

Not recommended.

Istalol Contraindications

Contraindications

Greater than 1st-degree AV block. Overt cardiac failure. Cardiogenic shock. Sinus bradycardia. Bronchial asthma. Severe COPD. History of bronchospasm. Not for use as a sole agent in angle-closure glaucoma.

Istalol Boxed Warnings

Not Applicable

Istalol Warnings/Precautions

Warnings/Precautions

History of cardiac failure. Discontinue at 1st sign of cardiac failure, and before surgery. Avoid abrupt cessation. Diabetes. May mask hypoglycemia, thyrotoxicosis. Myasthenia gravis. Cerebrovascular insufficiency. Contact lenses (remove; may reinsert 15 min after instillation). Pregnancy (Cat.C). Nursing mothers: not recommended.

Istalol Pharmacokinetics

See Literature

Istalol Interactions

Interactions

Avoid other topical β-blockers. May potentiate systemic β-blockers, reserpine, hypoglycemics, and mydriatic effect of topical epinephrine. May be potentiated by quinidine. May cause conduction defects with digoxin, calcium channel blockers (avoid concomitant use in impaired cardiac function).

Istalol Adverse Reactions

Adverse Reactions

Local irritation (burning, stinging), blurred vision, cataract, conjunctival injection, infection, headache, hypertension, itching. Systemic β-blocker effects (eg, bronchospasm, bradycardia, cardiac failure, muscle weakness).

Istalol Clinical Trials

See Literature

Istalol Note

Not Applicable

Istalol Patient Counseling

See Literature